Boc-3-Hydroxy-1-Adamantyl-D-Glycine CAS 361442-00-4 Puritas >99.5% EE >99.5%
Ruifu Chemical Supple Related Intermedia
CAS 361442-04-8
CAS 945667-22-1
(R) -1-Boc-3-Aminopiperidine CAS 188111-79-7
(R)-(-)-3-Aminopiperidine dihydrochloride CAS 334618-23-4
Boc-3-Hydroxy-1-Adamantyl-D-Glycine CAS 361442-00-4
(1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo [3.1.0]hexane-2-Carboxylic Acid tert-Butyl Ester CAS 361440-67-7
2-(3-Hydroxy-1-Adamantyl)-2-Acidum Oxoaceticum, CAS 709031-28-7
Nomen chemicum | Boc-3-Hydroxy-1-Adamantyl-D-Glycine |
Synonyma | (2S)-2-((tert-Butoxycarbonyl) amino) -2-(3-Hydroxyadamantan-1-yl) acidum aceticum |
CAS Number | 361442-00-4 |
CATTUS Number | RF-PI1989 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C17H27NO5 |
M. Pondus | 325.40 |
Ferveret | 497.3±20.0℃ |
Density | 1.296 |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Alba vel Off-White Crystalline pulveris |
Aquae (KF) | <0.50% |
Damnum in Siccatio | <1.00% |
Residere in Ignition | <0.50% |
una immunditia | <0.50% |
Totalis immunditias | <0.50% |
EE | >99.5% |
Puritas | >99.5% |
Infrared Imaginis | Conformat ut Structure |
Test Standard | Enterprise Standard |
Consuetudinem | Pharmaceutical intermedia |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
Boc-3-Hydroxy-1-Adamantyl-D-Glycine (CAS: 361442-00-4) medium est API (CAS: 361442-04-8).API (CAS: 361442-04-8)est potens et selectivus convertibilis inhibitor dipeptidyli peptidasi-4, quod augetur ad tractationem diabetarum speciei 2 .Celeriter post administrationem oralis absorbetur et profile pharmacokineticae compatitur cum semel dosing cotidie.Est dipeptidylus peptidase-4 (DPP-4) inhibitor antidiabeticus ad curationem diabete speciei 2 .DPP-4 inhibitores sunt genus compositorum quae laborant actionem hormonum naturalium in corpore incretino vocato afficientes.Ituna cum victu et exercitatione adhibetur ad sanguinem saccharo emendandum in adultis temperantia cum diabete 2 speciei melliti.Non est tractandi genus 1 diabete.Itinterdum adhibetur medicamentum cum aliis diabete.Perventum est ab cooperatione AstraZeneca et Bristol-Myers Squibb Societatis et ad inhibitorem DPP-IV pertinet.